Kinrix (DTaP-IPV) Vaccine

The FDA approved a new combination DTaP-IPV vaccine manufactured by GlaxoSmithKline in June, 2008. It is only approved as the booster dose at 4-6 years old, if the same brand of DTaP (either Infanrix or Pediarix) was given earlier.

References

CDC. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose. MMWR 2008;57(39).